Stefan Van Poucke’s Post

World leaders commit to decisive action on AMR! Global leaders approved The Political declaration at the 79th UNGA High-Level Meeting on AMR, committing to targets and actions including: ▶ reduce human deaths from AMR by 10% by 2030 ▶ increase to 60% the N of countries with funded NAP on AMR by 2030 ▶ at least 70% of antibiotics used for human health globally should belong to the WHO Access group ▶ 100% of countries having basic WASH in all health care facilities and 90% of countries meeting all WHO’s minimum requirements for IPC by 2030 On the environment, the declaration underscores the need to prevent and address the discharge of antimicrobials into the environment. All the links here below: 🔅 Joint Quadripartite press release: https://lnkd.in/dQQDyVnX 🔅 UN Web TV livestream recording for press conference https://lnkd.in/dzSXpPiw 🔅 Livestream link for HLM: https://lnkd.in/dgxfEQyj 🔅 https://lnkd.in/dQQDyVnX

Tackling Antimicrobial Resistance (AMR) from a One Health approach is important to human health, patients and people. On the 5th and 6th of September 2024, Dr Francesca Chiara, Chair of the Board of The AMR Narrative, moderated a One Health session at the World Anti-Microbial Resistance Congress in Philadelphia. Understanding that AMR is not confined to hospitals or healthcare settings is key to grasping the full scale of this global health threat. Read more about Dr Chiara's session here: https://lnkd.in/eREHUuQS #theAMRnarrative #AMR #AntimicrobialResistance #WorldAMRcongress

Awesome ECDC webinar about -how to communicate #AntimicrobialResistance "- I am listening to it this moment to be able to further support the fight against AMR!

🦠 Antimicrobial Resistance (#AMR) is a global health crisis, especially in developing regions where small-scale producers struggle with limited access to diagnostics. 🔬 Ceva Laprovet’s #OneLab Initiative, in partnership with GALVmed, is addressing this by bringing clinical #diagnostic services closer to small and medium-sized commercial farms. Read more about this: How Clinical Diagnostics Could Help the Global Fight Against Antimicrobial Resistance 👇 https://ow.ly/YNpP50TzYBu

🦠🌍 The Role of Diagnostics in the Fight Against Antimicrobial Resistance (AMR) In the recent declaration by world leaders at the United Nations, there was a clear commitment to decisive action on #AntimicrobialResistance. To turn this commitment into reality, there’s a critical piece of the puzzle we must address: Diagnostics.  The AMR crisis has been described as an arms race, one that we are not currently winning. Bacteria are evolving faster than our ability to develop new antibiotics. However, this arms race is not one we can win through antibiotics alone. 🔬 Better diagnostics are essential to break this cycle. Without rapid, precise diagnostics: - Patients continue to receive broad-spectrum antibiotics, driving resistance. - Healthcare providers are unable to target treatments effectively, leading to the overuse and misuse of antimicrobials. At inbiome, we are working to provide cutting-edge diagnostic solutions that empower healthcare professionals to detect pathogens faster and more accurately. Our advanced molecular diagnostics enable: ✅ Targeted therapies, minimizing unnecessary antibiotic use. ✅ Rapid identification of pathogens, allowing for precise treatment and improved patient outcomes. ✅ A proactive approach to slowing down the evolution of resistance. We believe that the fight against AMR can only be won through a combination of innovative diagnostics and therapy based on specific outcomes. At InBiome, we are proud to be part of this solution, ensuring that the future of global health is driven by precision and sustainability. 🌍💉🔎 #AMR #Diagnostics #GlobalHealth #AntibioticResistance #WHO #InBiome https://lnkd.in/eZXgY5Cv

I recently had the privilege of attending the High-Level Meeting on Antimicrobial Resistance at #UNGA79 virtually. This critical gathering emphasized the urgent need for global action against one of the most pressing public health threats of our time. Key takeaways: 1. AMR crisis: Caused an estimated 1.27 million deaths in 2019 and could cost up to $3.4 trillion in annual GDP losses by 2030. 2. One Health approach: The Quadripartite alliance (WHO Centre for Health Development, FAO, UNEP-WCMC, and World Organisation for Animal Health) is leading a collaborative effort across human, animal, and environmental health sectors. 3. Equity focus: LMICs are disproportionately affected, highlighting the need for international support and sustainable financing. 4. Innovation: New antibiotics, diagnostics, and surveillance systems are crucial to combat AMR effectively. 5. Public awareness: Education and involvement of diverse voices, especially from vulnerable populations, is essential. 6. Multisectoral action: Integrated surveillance, capacity-building, and sustainable resource allocation are key. 7. Political will: A new political declaration is expected to set measurable targets for global AMR action. The message was clear: AMR is a ticking time bomb that threatens to undo decades of medical progress. However, with collaborative efforts, innovative approaches, and sustained commitment, we can secure a future where effective antimicrobials remain available for all who need them.As healthcare professionals, researchers, and global citizens, we all have a role to play in combating AMR. What steps are you taking in your field to address this critical issue? #AntimicrobialResistance #GlobalHealth #UNGA79 #OneHealth #PublicHealth

Antimicrobial resistance (AMR) is one of the biggest threats to global health today. Following last week’s UN General Assembly High-Level Meeting on AMR, where commitments were made to improve equitable access to and appropriate use of antimicrobials, as well as to enhance reporting and surveillance of antimicrobial use across all sectors, the urgency for action has never been more apparent. AMR threatens nearly every aspect of health and medical research. Without effective antimicrobials, such as antibiotics for treating common bacterial infections, we risk returning to the 'dark ages' of medicine, with serious economic repercussions. Research Australia is proud to support our members who are leading the charge in addressing this critical issue. Together, we’re helping to ensure that Australian health and medical research leads the way in fighting this global challenge. #ResearchAustralia #AMR #AustralianHMR Read more: https://lnkd.in/e64smPvR

Future generations will appreciate Leaders who pay close attention to sustainability, One Health, and a unified healthcare system. Antimicrobial resistance (AMR) doesn’t just impact animals; it affects humans as well. We are facing a future where new antibiotics may no longer be effective against emerging microbes.

Monitoring and Evaluation of National Action Plans on Antimicrobial Resistance The aim of this course is to provide guidance for countries on the monitoring and evaluation of national action plans on antimicrobial resistance (AMR NAPs). This course is intended for members of the AMR multisectoral coordination committee or working group, persons responsible for M&E in AMR NAPs and other key actors involved in NAP implementation across all relevant sectors. The guidance may also be useful for M&E experts and One Health coordination committee members at the national and subnational levels. Course information Overview AMR is one of the top 10 global health threats currently facing the world. It is a complex public health threat whose root causes are found in sectors ranging from human health, animal husbandry, food safety and agriculture to environment and trade. Countries have developed national action plans to combat the threat of AMR. Effective implementation of these plans requires collaboration and coordinated action within, and across diverse sectors and disciplines, with a broad range of stakeholders. To support countries to achieve evidence-based and sustainable implementation and monitoring of their national action plans, the Quadripartite agencies – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) – have developed guidance for countries on monitoring and evaluation of AMR NAPs. Countries are expected to develop a monitoring and evaluation (M&E) plan for their NAP, tailored to their context and priorities. This course has been designed to support countries by providing information on how to establish an M&E plan for their AMR NAP. Course duration Approximately 2 hours Certificate A certificate of achievement will be available to participants who score at least 80% in the final assessment . Participants who receive a certificate of achievement can also download an Open Badge for this course. What you'll learn Summarize the M&E framework for the global action plan on antimicrobial resistance (GAP-AMR) and its recommended indicators List the 8 steps to establish a national M&E plan Describe the basic concepts of monitoring, evaluation, and development of SMART indicators Explain key considerations for developing an M&E plan Outline the basic principles that need to be kept in mind when developing an M&E plan Recognize the importance of monitoring and evaluating progress in AMR NAP implementation More details at: https://lnkd.in/gx4y9erM

Excited to see our work at the World Health Organization (WHO) Office at the United Nations gathering media attention! Over the past months, our office has been assisting with negotiations between Member States on targets, action items, and focus points in the Political Declaration on Antimicrobial Resistance. These discussions, superbly led by the delegations of Barbados and Malta, have been insightful in demonstrating the intricacies of this global problem. This article highlights that reaching a consensus on this wide-ranging issue is no easy task. On one hand, we hope to set bold, ambitious targets through a One Health approach, ensuring that all relevant sectors of AMR are mobilized, including: 👩⚕️ Human Health 🐮 Animal Health 🌻 Plant Health 🌽 Food and Agriculture 🏞 Environmental Health However, significant disparities exist within and among countries, in areas such as: 💰 Health Financing 🕵♂️ Surveillance and Testing 🚰 Water, Sanitation, and Hygiene 😷 Infection Prevention & Control 💊 Access to Advanced Antimicrobials 🏭 Manufacturing Capacity ♻ Environmental Protections 🏫 Education Quality and Accessibility 🏥 Health and Science Workforce 🔬 Research and Development Importantly, oftentimes the countries that are most affected by antimicrobial resistance also have the most trouble mobilizing resources and require the most dedicated global support. I've witnessed the incredible amount of work necessary to craft an ambitious and forward-looking document, while still attempting to maintain as much global consensus among Member States as possible. As we approach the High-Level Meeting on Antimicrobial Resistance, I hope this Political Declaration revitalizes the global push towards prudent and responsible antimicrobial use, ensuring a safer, healthier, and more equitable future for us all!